Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R E Jordan

Showing results (101-110 of 116) with videos related to

Pageof 12
Sort By:
Thrombosis and Haemostasis|May 25, 2001
7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesisP M Sassoli, E L Emmell, S H Tam, et al.
Journal of Thrombosis and Thrombolysis|December 10, 1999
Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitroN S Kleiman, N Graziadei, R E Jordan, et al.
NPJ Primary Care Respiratory Medicine|November 25, 2018
Systematic review of the effectiveness of community-based self-management interventions among primary care COPD patientsK Jolly, M S Sidhu, E Bates, et al.
Circulation|December 24, 1997
Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapyM A Mascelli, S Worley, N J Veriabo, et al.
American Heart Journal|July 1, 1999
Readministration of abciximab: interim report of the ReoPro readministration registryJ E Tcheng, D J Kereiakes, G A Braden, et al.
Archives of Dermatology|November 1, 1980
Reliability of indirect immunofluorescence testingT P Chorzelski, S Jablonska, M Jarzabek-Chorzelska, et al.
Birth Defects Original Article Series|January 1, 1975
Ehlers-Danlos type V (X-linked form): a lysyl oxidase deficiencyN Di Ferrante, R D Leachman, P Angelini, et al.
Circulation|February 18, 1997
Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosisR R Makkar, F Litvack, N L Eigler, et al.
American Heart Journal|August 31, 2000
Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventionsN S Kleiman, N Grazeiadei, K Maresh, et al.
Vaccine|October 16, 2007
A case-control study of elderly patients with acute respiratory illness: effect of influenza vaccination on admission to hospital in winter 2003-2004R E Jordan, J I Hawker, J G Ayres, et al.
Pageof 12

Showing results (101-110 of 116) with videos related to

Sort By:
Pageof 12
Thrombosis and Haemostasis|May 25, 2001
7E3 F(ab')2, an effective antagonist of rat alphaIIbbeta3 and alphavbeta3, blocks in vivo thrombus formation and in vitro angiogenesisP M Sassoli, E L Emmell, S H Tam, et al.
Journal of Thrombosis and Thrombolysis|December 10, 1999
Ticlopidine enhances the platelet inhibitory capacity of abciximab in vitroN S Kleiman, N Graziadei, R E Jordan, et al.
NPJ Primary Care Respiratory Medicine|November 25, 2018
Systematic review of the effectiveness of community-based self-management interventions among primary care COPD patientsK Jolly, M S Sidhu, E Bates, et al.
Circulation|December 24, 1997
Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapyM A Mascelli, S Worley, N J Veriabo, et al.
American Heart Journal|July 1, 1999
Readministration of abciximab: interim report of the ReoPro readministration registryJ E Tcheng, D J Kereiakes, G A Braden, et al.
Archives of Dermatology|November 1, 1980
Reliability of indirect immunofluorescence testingT P Chorzelski, S Jablonska, M Jarzabek-Chorzelska, et al.
Birth Defects Original Article Series|January 1, 1975
Ehlers-Danlos type V (X-linked form): a lysyl oxidase deficiencyN Di Ferrante, R D Leachman, P Angelini, et al.
Circulation|February 18, 1997
Effects of GP IIb/IIIa receptor monoclonal antibody (7E3), heparin, and aspirin in an ex vivo canine arteriovenous shunt model of stent thrombosisR R Makkar, F Litvack, N L Eigler, et al.
American Heart Journal|August 31, 2000
Abciximab, ticlopidine, and concomitant abciximab-ticlopidine therapy: ex vivo platelet aggregation inhibition profiles in patients undergoing percutaneous coronary interventionsN S Kleiman, N Grazeiadei, K Maresh, et al.
Vaccine|October 16, 2007
A case-control study of elderly patients with acute respiratory illness: effect of influenza vaccination on admission to hospital in winter 2003-2004R E Jordan, J I Hawker, J G Ayres, et al.
Pageof 12